Ten Things You Need To Be Aware Of ADHD Medication Pregnancy > 자유게시판

• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

adhd over the counter medication uk Medication During Pregnancy and Breastfeeding

Women suffering from ADHD must make a difficult decision regarding whether or not to stop taking ADHD medication during pregnancy and breastfeeding. There aren't enough data regarding how exposure over time may affect a foetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders such as hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for higher-quality studies.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication should consider the benefits of taking it against the potential dangers for the foetus. Doctors don't have the information needed to provide clear recommendations, but they can provide information about risks and benefits that aid pregnant women in making informed decisions.

A study published in Molecular Psychiatry found that women who were taking ADHD medications in early pregnancy did not have a significantly increased risk of fetal heart malformations or major birth defects that are structural. Researchers conducted a massive population-based study of case control to examine the prevalence of major structural defects in infants born to mothers who took stimulants during pregnancy. Clinical geneticists and pediatric cardiologists examined the cases to ensure an accurate case classification and to limit the possibility of bias.

However, the study had its limitations. In particular, they were unable to separate the effects of the medication from those of the underlying disorder. That limitation makes it difficult to determine whether the limited associations observed in the exposed groups are due to medication use or comorbidities that cause confusion. The researchers did not study long-term outcomes for the offspring.

The study found that babies whose mothers took ADHD medication during pregnancy had a greater risk of being admitted to the neonatal care unit (NICU), compared to mothers who did not use any medication during pregnancy or had discontinued taking their medication prior to or during pregnancy. This increase was due to central nervous system-related disorders, and the increased risk of admission did not appear to be affected by the type of stimulant medication was used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher chance of having to have caesarean sections or a baby that scored low on the Apgar scale (less than 7). These increases didn't appear to be affected by the type of medication that was used during pregnancy.

Researchers suggest that the minor risk of using ADHD medications during early pregnancies can be offset by greater benefits for mother and baby of continuing treatment for the woman's disorder. Physicians should discuss the issue with their patients and, where possible, assist them in developing strategies to improve coping skills that may minimize the negative impact of her condition on her daily functioning and relationships.

Interactions with Medication

Doctors are increasingly faced with the decision of whether to maintain treatment or stop it during pregnancy as more women are diagnosed with ADHD. Often, these decisions are made without any evidence that is clear and definitive regardless, so doctors must weigh their knowledge from their own experiences, those of other doctors, and what the research suggests on the subject and their own judgments for each individual patient.

The issue of potential risks to the infant can be particularly tricky. Many of the studies on this topic are based on observations instead of controlled research and their findings are often contradictory. Most studies focus on live births, which may underestimate the teratogenic impact which can cause terminations or abortions of pregnancy. The study presented in the journal club addresses these issues by analyzing information on deceased and live births.

The conclusion: While some studies have found an association between ADHD medications and the possibility of certain birth defects, others have not found any evidence of a link and the majority of studies demonstrate a neutral or slightly negative effect. As a result an accurate risk-benefit analysis must be done in each situation.

It can be difficult, if not impossible for women with ADHD to stop taking their medication. In fact, in a recent article in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping adhd without medication medication during pregnancy can cause depression, feelings of loneliness and family conflict for these patients. Furthermore, a loss of medication can interfere with the ability to do work-related tasks and safely drive that are crucial aspects of daily life for many people suffering from ADHD.

She suggests women who are uncertain about whether to continue or discontinue medication due to their pregnancy, consider educating family members, friends and colleagues about the condition, its effects on daily functioning, and on the advantages of staying on the current treatment regimen. In addition, educating them can help the woman feel supported as she struggles with her decision. It is also worth noting that certain medications are able to pass through the placenta, so if the patient decides to stop taking her ADHD medication during pregnancy and breastfeeding, she must be aware that traces of the medication could be passed on to the baby.

Risk of Birth Defects

As the use and use of ADHD medication to treat adhd without medication adults symptoms of attention deficit disorder hyperactivity disorder (ADHD), increases, so does concern about the possible effects of the drugs on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this subject. With two massive data sets researchers were able look at more than 4.3 million pregnancies to determine whether stimulant medications increased the risk of birth defects. While the overall risk is low, the researchers did find that first-trimester exposure to ADHD medicines was associated with an increased risk of certain heart defects like ventriculo-septal defects (VSD).

The authors of the study found no association between early use of medication and other congenital anomalies, like facial clefting, or club foot. The results are in the same vein as previous studies that showed an insignificant, but small increase in the number of cardiac malformations among women who began taking ADHD medication before the time of pregnancy. This risk increased during the latter part of pregnancy, when a lot of women began to stop taking their medication.

Women who took ADHD medication in the first trimester were more likely to need a caesarean, have an insufficient Apgar after delivery, and have a baby who needed breathing assistance at birth. The authors of the study were unable to remove bias in selection since they restricted the study to women without other medical conditions that could have contributed to the findings.

The researchers hope their study will aid in the clinical decisions of physicians who encounter pregnant women. The researchers suggest that, while discussing risks and benefits are important, the choice on whether to continue or stop medication should be in light of the severity of each woman's ADHD symptoms and the needs of the woman.

The authors warn that, although stopping the medication is a possibility to think about, it isn't recommended because of the high incidence of depression and other mental disorders in women who are expecting or have recently given birth. Research has also shown that women who stop taking their medication will have a harder adjustment to life without them after the baby is born.

Nursing

It can be overwhelming to become a mom. Women with ADHD who have to deal with their symptoms while attending physician appointments and getting ready for the arrival of a child and adjusting to new household routines are often faced with a number of difficulties. Many women choose to continue taking their adhd medication without diagnosis uk medication during pregnancy.

The majority of stimulant drugs pass through breast milk in small amounts, so the risk for nursing infant is very low. The amount of exposure to medications can vary depending upon the dosage the medication is administered, its frequency and the time of the day. In addition, different medications are introduced into the baby's system through the gastrointestinal tract or breast milk. The impact on the health of a newborn is not fully known.

Some physicians may discontinue stimulant medication during a woman’s pregnancy due to the lack of research. This is a complicated decision for the patient, who must balance the benefits of continuing her medication against the potential dangers to the foetus. As long as there is no more information, doctors should ask all pregnant patients about their experience with ADHD and if they are taking or planning to take medication during the perinatal time.

Many studies have shown that women can my general practitioner prescribe adhd medication continue to take their adhd medications for adults with anxiety medication safely during pregnancy and while breast-feeding. In response, a growing number of patients are choosing to continue their medication. They have concluded, in consultation with their doctor, that the benefits of retaining their current medication outweigh potential risks.

It is essential for women with ADHD who are contemplating breastfeeding to seek out a specialist psychiatrist's advice prior to becoming pregnant. They should discuss their medication with their doctor and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological management strategies. Psychoeducation should also be provided to help pregnant women suffering from ADHD understand their symptoms and the underlying disorder Learn about the available treatment options and reinforce existing strategies for coping. This should include an approach that is multidisciplinary, including the GP, obstetricians and psychiatry. Pregnancy counseling should include a discussion of a treatment plan for the mother and the child, monitoring of signs of deterioration and, if needed, adjustments to the medication regimen.